County
Giles County EMS
Giles County EMS (TN) carries 31 drugs across 152 dose entries in its current published protocol, effective 2026-03-30.
Drugs and doses31
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 650–1000 mg | PO | not captured | standing | page 70 |
| Mild to moderate pain | adult | 650–1000 mg | IV | not captured | standing | page 70 |
| Mild to moderate pain | peds | 15 mg/kg | PO | not captured | standing | page 70 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| SVT | adult | 12 mg | IV/IO | not captured | standing | page 21 |
| SVT | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 21 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 2.5 mg | NEB | not captured | standing | page 30 |
| Anaphylaxis | peds | 2.5 mg | NEB | not captured | standing | page 30 |
| Hyperkalemia | adult | 5 mg | NEB | not captured | standing | page 19 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 150 mg | IV/IO | not captured | standing | page 23 |
| Other | peds | 5 mg/kg | IV/IO | not captured | standing | page 23 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | page 27 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | page 27 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | page 12 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | page 17 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 17 |
| Organophosphate poisoning | adult | 2–3 mg | IV/IO/IM | not captured | standing | page 82 |
| Organophosphate poisoning | peds | 0.05 mg/kg | IV/IO/IM | not captured | standing | page 82 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 500–1000 mg | IV/IO | not captured | standing | page 19 |
| Cardiac arrest | peds | 20 mg/kg | IV/IO | not captured | standing | page 19 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 g | IV/IO | not captured | standing | page 51 |
Dexamethasone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 4 mg | IV/IO | not captured | standing | page 138 |
| Adrenal crisis | adult | 4 mg | IV | not captured | standing | page 74 |
| Allergic reaction | adult | 10 mg | IV/IM | not captured | standing | page 65 |
| Allergic reaction | peds | 0.6 mg/kg | IV/IM | not captured | standing | page 65 |
| Asthma / bronchospasm | adult | 10 mg | IV/IO/IM | not captured | standing | page 52 |
| Asthma / bronchospasm | peds | 0.6 mg/kg | IV/IO/IM | not captured | standing | page 52 |
| Croup | peds | 0.6 mg/kg | PO | not captured | standing | page 52 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 15–25 g | PO | not captured | standing | page 68 |
| Hypoglycemia | peds | 0.5 g/kg | IV/IO | not captured | standing | page 68 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 10–20 mg | IV/IO | not captured | standing | page 21 |
| Atrial fibrillation with RVR | adult | 10–20 mg | IV/IO | not captured | standing | page 21 |
| Other | adult | 10–20 mg | IV/IO | not captured | standing | page 140 |
| SVT | adult | 10–20 mg | IV/IO | not captured | standing | page 140 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 25–50 mg | IV/IO/IM | not captured | standing | page 65 |
| Allergic reaction | peds | 1 mg/kg | IV/IO/IM | not captured | standing | page 65 |
| Anaphylaxis | adult | 25–50 mg | IV/IO/IM | not captured | standing | page 65 |
| Anaphylaxis | peds | 1 mg/kg | IV/IO/IM | not captured | standing | page 65 |
| Dystonic reaction | adult | 25–50 mg | IV/IO/IM | not captured | standing | page 71 |
| Dystonic reaction | peds | 1 mg/kg | IV/IO/IM | not captured | standing | page 71 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3 mg | IM | not captured | standing | page 65 |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | page 65 |
| Asthma / bronchospasm | adult | 0.3 mg | IM | not captured | standing | page 53 |
| Asthma / bronchospasm | peds | 0.01 mg/kg | IM | not captured | standing | page 53 |
| Bradycardia | adult | 2–10 mcg | IV/IO | not captured | standing | page 18 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | page 26 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 26 |
| Croup | adult | 1 mg | NEB | not captured | standing | page 52 |
| Croup | peds | 1 mg | NEB | not captured | standing | page 52 |
| Other | peds | 1 mg | NEB | not captured | standing | page 52 |
Famotidine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 20 mg | IV/IO | not captured | standing | page 65 |
| Anaphylaxis | adult | 20 mg | IV/IO | not captured | standing | page 65 |
| Anaphylaxis | peds | 1 mg/kg | IV/IO | not captured | standing | page 65 |
| Other | adult | 20 mg | IV/IO | not captured | standing | page 144 |
| Other | peds | 1 mg/kg | IV/IO | not captured | standing | page 144 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 1–1.5 mcg/kg | IV/IO | not captured | standing | page 81 |
| Mild to moderate pain | adult | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | page 12 |
| Mild to moderate pain | peds | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | page 12 |
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 1 mg | IV/IO | not captured | standing | page 82 |
| Beta-blocker / calcium-channel-blocker overdose | adult | 1–2 mg | IV/IM | not captured | standing | page 18 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.5 mg | IV/IM | not captured | standing | page 18 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.5 mg | IV/IO | not captured | standing | page 82 |
| Hypoglycemia | adult | 1 mg | IM | not captured | standing | page 68 |
| Hypoglycemia | adult | 1 mg | IN | not captured | standing | page 68 |
| Hypoglycemia | peds | 1 mg | IM | not captured | standing | page 68 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 0.5 mg | NEB | not captured | standing | page 52 |
| Asthma / bronchospasm | peds | 0.5 mg | NEB | not captured | standing | page 52 |
| COPD | adult | 0.5 mg | NEB | not captured | standing | page 52 |
| COPD | peds | 0.5 mg | NEB | not captured | standing | page 52 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperactive delirium | adult | 3–5 mg/kg | IM | not captured | standing | page 119 |
| Other | adult | 1 mg/kg | IV/IO | not captured | standing | page 89 |
| Other | adult | 2 mg/kg | IM | not captured | standing | page 89 |
| Other | peds | 1 mg/kg | IV/IO | not captured | standing | page 89 |
| Other | peds | 2 mg/kg | IM | not captured | standing | page 89 |
| Mild to moderate pain | adult | 0.5–1 mg/kg | IM/IN | not captured | standing | page 81 |
| RSI induction | adult | 1–2 mg/kg | IV/IO | not captured | standing | page 54 |
| RSI induction | peds | 1–2 mg/kg | IV/IO | not captured | standing | page 54 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 15 mg | IV/IO | not captured | standing | page 80 |
| Other | adult | 30 mg | IM | not captured | standing | page 80 |
| Mild to moderate pain | adult | 15 mg | IV/IO | not captured | standing | page 80 |
| Mild to moderate pain | adult | 15 mg | IV/IO | not captured | standing | page 80 |
| Mild to moderate pain | adult | 30 mg | IM | not captured | standing | page 80 |
| Mild to moderate pain | adult | 30 mg | IM | not captured | standing | page 80 |
| Trauma / hemorrhage | adult | 15 mg | IV/IO | not captured | standing | page 80 |
| Trauma / hemorrhage | adult | 30 mg | IM | not captured | standing | page 80 |
Labetalol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Eclampsia / pre-eclampsia | adult | 10 mg | IV/IO | not captured | standing | page 51 |
| Eclampsia / pre-eclampsia | adult | 10 mg | IV/IO | not captured | standing | page 51 |
| Other | adult | 10 mg | IV/IO | not captured | standing | page 72 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1.5 mg/kg | IV/IO | not captured | standing | page 151 |
| Other | adult | 1.5 mg/kg | IV/IO | not captured | standing | page 151 |
| Other | peds | 1 mg/kg | IV/IO | not captured | standing | page 151 |
| Other | peds | 1 mg/kg | IV/IO | not captured | standing | page 151 |
| Mild to moderate pain | adult | 20–40 mg | IO | not captured | standing | page 76 |
| Mild to moderate pain | peds | 0.5 mg/kg | IO | not captured | standing | page 76 |
| Wide-complex tachycardia | adult | 1.5 mg/kg | IV/IO | not captured | standing | page 23 |
| Wide-complex tachycardia | peds | 1 mg/kg | IV/IO | not captured | standing | page 23 |
| VF / pulseless VT | adult | 1.5 mg/kg | IV/IO | not captured | standing | page 23 |
| VF / pulseless VT | peds | 1 mg/kg | IV/IO | not captured | standing | page 23 |
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2 g | IV/IO | not captured | standing | page 52 |
| Asthma / bronchospasm | adult | 2 g | IV/IO | not captured | standing | page 52 |
| Asthma / bronchospasm | adult | 2 g | IV/IO | not captured | standing | page 52 |
| Asthma / bronchospasm | peds | 75 mg/kg | IV/IO | not captured | standing | page 52 |
| Asthma / bronchospasm | peds | 75 mg/kg | IV/IO | not captured | standing | page 52 |
| Asthma / bronchospasm | peds | 75 mg/kg | IV/IO | not captured | standing | page 52 |
| Eclampsia / pre-eclampsia | adult | 4 g | IV/IO | not captured | standing | page 51 |
| Other | adult | 2 g | IV/IO | not captured | standing | page 27 |
| Other | peds | 50 mg/kg | IV/IO | not captured | standing | page 27 |
| VF / pulseless VT | adult | 2 g | IV/IO | not captured | standing | page 23 |
| VF / pulseless VT | peds | 50 mg/kg | IV/IO | not captured | standing | page 23 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 153 |
| Eclampsia / pre-eclampsia | adult | 2.5–5 mg | IV/IO/IN | not captured | standing | page 51 |
| Other | adult | 1–2.5 mg | IV/IO/IM/IN | not captured | standing | page 81 |
| Other | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 81 |
| Post-intubation sedation | adult | 0.1 mg/kg | IV | not captured | standing | page 81 |
| Procedural sedation | adult | 2–2.5 mg | IV/IO/IM/IN | not captured | standing | page 17 |
| Seizure | adult | 5 mg | IM/IN | not captured | standing | page 71 |
| Seizure | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 71 |
| Narrow-complex tachycardia | adult | 1–2.5 mg | IV/IO/IN | not captured | standing | page 22 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 2 mg | IN | not captured | standing | page 82 |
| Hypothermia | adult | 0.4 mg | IV/IO/IM/IN | not captured | standing | page 94 |
| Hypothermia | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 94 |
| Opioid overdose | adult | 0.5–2 mg | IV/IO/IM/IN | not captured | standing | page 82 |
| Opioid overdose | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 82 |
| Stroke | adult | 0.4 mg | IV/IO/IM/IN | not captured | standing | page 84 |
| Stroke | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 84 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | page 12 |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | page 30 |
| Other | adult | 0.4 mg | SL | not captured | standing | page 72 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 2–30 mcg | IV/IO | not captured | standing | page 73 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | IV/IM | not captured | standing | page 67 |
| Nausea / vomiting | adult | 4 mg | PO | not captured | standing | page 67 |
| Nausea / vomiting | adult | 4 mg | IV/IO | not captured | standing | page 67 |
| Nausea / vomiting | peds | 0.15 mg/kg | IV/IM | not captured | standing | page 67 |
| Nausea / vomiting | peds | 0.15 mg/kg | IV/IO | not captured | standing | page 67 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 15–25 g | PO | not captured | standing | page 68 |
| Hypoglycemia | peds | 15–25 g | PO | not captured | standing | page 68 |
Promethazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 12.5–25 mg | IM | not captured | standing | page 67 |
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 1 mEq/kg | IV/IO | not captured | standing | page 27 |
| Cardiac arrest | peds | 1 mEq/kg | IV/IO | not captured | standing | page 27 |
| Hyperkalemia | adult | 50 mEq | IV | not captured | standing | page 19 |
| Hyperkalemia | peds | 1 mEq/kg | IV | not captured | standing | page 19 |
| Other | adult | 1 mEq/kg | IV/IO | not captured | standing | page 23 |
| Other | peds | 1 mEq/kg | IV/IO | not captured | standing | page 23 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 1 g | IV/IO | not captured | standing | page 65 |
| Head injury / TBI | adult | 2 g | IV | not captured | standing | page 88 |
| Obstetric hemorrhage | adult | 1 g | IV | not captured | standing | page 47 |
| Other | adult | 1 g | NEB | not captured | standing | page 69 |
| Other | adult | 2 g | IV | not captured | standing | page 69 |
| Other | adult | 2 g | IV | not captured | standing | page 67 |
| Trauma / hemorrhage | adult | 2 g | IV | not captured | standing | page 88 |
| Trauma / hemorrhage | adult | 2 g | IV | not captured | standing | page 160 |
| Trauma / hemorrhage | adult | 2 g | IV | not captured | standing | page 88 |
| Trauma / hemorrhage | adult | 2 g | IV | not captured | standing | page 69 |